Conditional cancer survival of the corpus uterine in the USA



To identify relative survival probabilities for corpus uterine cancer patients accounting for time already survived, as well as age, race, ethnicity, marital status, tumor stage, and tumor grade at diagnosis.


Analyses are based on 78,147 women diagnosed with corpus uterine cancer during 2000-2008 and followed through 2013, using data from the National Cancer Institute Surveillance, Epidemiology, and End Results (SEER) program.


Age, race, marital status, tumor stage, and tumor grade, but not ethnicity, significantly impacted relative cancer survival rates of the corpus uterine. Improvement in 5-year relative survival, when conditioned on 1-5 years already survived, occurs in each stage category, more so in later staged cases. The effect of age, race, marital status, and tumor grade on 5-year relative survival, after conditioning on years (1-2-3-4-5) already survived, varied by stage at diagnosis. For example, poorer prognosis with older age was only observed for regional and distant staged cases, but being married had a greater beneficial impact in regional and distant staged cases. The difference in 5-year relative survival rates diminished for age, race, marital status, tumor stage and grade when conditioned on years (1-2-3-4-5) already survived. The greatest improvement in 5-year conditional relative survival was in patients 70 years or older, Blacks, singles, later staged tumors, and higher grade tumors.


Reporting cancer survival estimates according to time already survived and demographic subgroups provide health-care providers and patients with more instructive prognostic information.

J Endometr Pelvic Pain Disord 2016; 8(4): 172 - 177




Ray M. Merrill, Aaron M. Frutos

Article History


Financial support: No grants or funding have been received for this study.
Conflict of interest: None of the authors has financial interest related to this study to disclose.

This article is available as full text PDF.

  • If you are a Subscriber, please log in now.

  • Article price: Eur 36,00
  • You will be granted access to the article for 72 hours and you will be able to download any format (PDF or ePUB). The article will be available in your login area under "My PayPerView". You will need to register a new account (unless you already own an account with this journal), and you will be guided through our online shop. Online purchases are paid by Credit Card through PayPal.
  • If you are not a Subscriber you may:
  • Subscribe to this journal
  • Unlimited access to all our archives, 24 hour a day, every day of the week.



  • Department of Health Science at Brigham Young University, Provo, Utah - USA

Article usage statistics

The blue line displays unique views in the time frame indicated.
The yellow line displays unique downloads.
Views and downloads are counted only once per session.

No supplementary material is available for this article.